CD4 and Cirrhosis: LSECs ability to stimulate a pro-inflammatory CD4+ Th17 cell expansion in CCl4 and their differential response to an acute bacterial challenge in the context of cirrhosis pointed to specific inflammatory modulating mechanisms in experimental models of liver disease.